An intervention to increase physical activity in care home residents: results of a cluster-randomised, controlled feasibility trial (the REACH trial).

cluster randomised feasibility trial long-term care older people physical activity staff training

Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
10 11 2021
Historique:
received: 21 12 2020
pubmed: 26 7 2021
medline: 17 11 2021
entrez: 25 7 2021
Statut: ppublish

Résumé

Care home (CH) residents are mainly inactive, leading to increased dependency and low mood. Strategies to improve activity are required. Cluster randomised controlled feasibility trial with embedded process and health economic evaluations. Twelve residential CHs in Yorkshire, United Kingdom, were randomised to the MoveMore intervention plus usual care (UC) (n = 5) or UC only (n = 7). Permanent residents aged ≥65 years. MoveMore: a whole home intervention involving all CH staff designed to encourage and support increase in movement of residents. Feasibility objectives relating to recruitment, intervention delivery, data collection and follow-up and safety concerns informed the feasibility of progression to a definitive trial. Data collection at baseline, 3, 6 and 9 months included: participants' physical function and mobility, perceived health, mood, quality of life, cognitive impairment questionnaires; accelerometry; safety data; intervention implementation. 300 residents were screened; 153 were registered (62 MoveMore; 91 UC). Average cluster size: MoveMore: 12.4 CHs; UC: 13.0 CHs. There were no CH/resident withdrawals. Forty (26.1%) participants were unavailable for follow-up: 28 died (12 MoveMore; 16 UC); 12 moved from the CH. Staff informant/proxy data collection for participants was >80%; data collection from participants was <75%; at 9 months, 65.6% of residents provided valid accelerometer data; two CHs fully, two partially and one failed to implement the intervention. There were no safety concerns. Recruiting CHs and residents was feasible. Intervention implementation and data collection methods need refinement before a definitive trial. There were no safety concerns.

Sections du résumé

BACKGROUND
Care home (CH) residents are mainly inactive, leading to increased dependency and low mood. Strategies to improve activity are required.
DESIGN AND SETTING
Cluster randomised controlled feasibility trial with embedded process and health economic evaluations. Twelve residential CHs in Yorkshire, United Kingdom, were randomised to the MoveMore intervention plus usual care (UC) (n = 5) or UC only (n = 7).
PARTICIPANTS
Permanent residents aged ≥65 years.
INTERVENTION
MoveMore: a whole home intervention involving all CH staff designed to encourage and support increase in movement of residents.
OBJECTIVES AND MEASUREMENTS
Feasibility objectives relating to recruitment, intervention delivery, data collection and follow-up and safety concerns informed the feasibility of progression to a definitive trial. Data collection at baseline, 3, 6 and 9 months included: participants' physical function and mobility, perceived health, mood, quality of life, cognitive impairment questionnaires; accelerometry; safety data; intervention implementation.
RESULTS
300 residents were screened; 153 were registered (62 MoveMore; 91 UC). Average cluster size: MoveMore: 12.4 CHs; UC: 13.0 CHs. There were no CH/resident withdrawals. Forty (26.1%) participants were unavailable for follow-up: 28 died (12 MoveMore; 16 UC); 12 moved from the CH. Staff informant/proxy data collection for participants was >80%; data collection from participants was <75%; at 9 months, 65.6% of residents provided valid accelerometer data; two CHs fully, two partially and one failed to implement the intervention. There were no safety concerns.
CONCLUSIONS
Recruiting CHs and residents was feasible. Intervention implementation and data collection methods need refinement before a definitive trial. There were no safety concerns.

Identifiants

pubmed: 34304268
pii: 6326056
doi: 10.1093/ageing/afab130
pmc: PMC8581372
doi:

Banques de données

ISRCTN
['ISRCTN16076575']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2063-2078

Subventions

Organisme : Department of Health
ID : RP-PG-1210-12017
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Age Ageing. 2020 Aug 24;49(5):821-828
pubmed: 32232434
Trials. 2019 Oct 22;20(Suppl 1):579
pubmed: 31639031
Trials. 2018 Oct 3;19(1):535
pubmed: 30285850
BMJ. 2015 Feb 05;350:h468
pubmed: 25657106
J Aging Phys Act. 2015 Jan;23(1):133-43
pubmed: 24515976
Health Technol Assess. 2020 Mar;24(16):1-172
pubmed: 32216870
Aging Ment Health. 2011 May;15(4):475-81
pubmed: 21500014
Exp Gerontol. 2017 Dec 15;100:63-69
pubmed: 29107061
Trials. 2017 Apr 19;18(1):182
pubmed: 28424088
Psychol Med. 2007 May;37(5):737-46
pubmed: 17176501
BMC Public Health. 2014 Apr 09;14:333
pubmed: 24712381
Eur J Pain. 2014 Nov;18(10):1490-500
pubmed: 24819710
Qual Life Res. 2005 Dec;14(10):2197-214
pubmed: 16328900
Am J Health Promot. 2016 May;30(5):314-22
pubmed: 27404639
Med Sci Sports Exerc. 2013 Aug;45(8):1493-500
pubmed: 23475142
Int Disabil Stud. 1988;10(2):61-3
pubmed: 3403500
Qual Life Res. 2020 Feb;29(2):463-472
pubmed: 31646416
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Phys Ther. 1984 Jan;64(1):35-40
pubmed: 6691052
Physiotherapy. 2020 Jun;107:50-57
pubmed: 32026835
J Am Geriatr Soc. 2005 Nov;53(11):1881-8
pubmed: 16274368
Curr Cardiol Rep. 2016 Jan;18(1):6
pubmed: 26699633
BMC Public Health. 2015 Jan 31;15:65
pubmed: 25637282
Int J Geriatr Psychiatry. 1999 Nov;14(11):936-40
pubmed: 10556864
Biomed Res Int. 2017;2017:9160504
pubmed: 28913360
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004294
pubmed: 23450551
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Gerontol A Biol Sci Med Sci. 2015 Jan;70(1):119-24
pubmed: 25324221
J Clin Epidemiol. 2014 Sep;67(9):1035-43
pubmed: 24837298
Age Ageing. 2006 Nov;35(6):586-91
pubmed: 16905764
Pain Manag Nurs. 2015 Aug;16(4):464-74
pubmed: 26256216
Lancet. 2013 Jul 6;382(9886):41-9
pubmed: 23643112
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Age Ageing. 2016 Sep;45(5):652-61
pubmed: 27207749
J Nutr Health Aging. 2016;20(7):752-8
pubmed: 27499309

Auteurs

Anne Forster (A)

Academic Unit for Ageing and Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Leeds Institute of Health Sciences, University of Leeds, Leeds, West Yorkshire, UK.

Jennifer Airlie (J)

Academic Unit for Ageing and Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Alison Ellwood (A)

Centre for Dementia Studies, University of Bradford, Bradford, UK.

Mary Godfrey (M)

Academic Unit for Ageing and Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Leeds Institute of Health Sciences, University of Leeds, Leeds, West Yorkshire, UK.

John Green (J)

Academic Unit for Ageing and Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Bonnie Cundill (B)

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds UK.

Bryony Dawkins (B)

Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Nicola McMaster (N)

NHS England and NHS Improvement, Leeds, UK.

Claire Hulme (C)

Institute of Health Research, College of Medicine and Health, University of Exeter, Exeter, UK.

Robert Cicero (R)

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds UK.

Vicki McLellan (V)

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds UK.

Liz Graham (L)

Academic Unit for Ageing and Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Bev Gallagher (B)

NHS Bradford District and Craven Clinical Commissioning Group, Bradford, UK.

David R Ellard (DR)

Warwick Clinical Trials Unit, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Joan Firth (J)

Patient and Public Involvement Contributor, Ilkley, UK.

Amanda Farrin (A)

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH